
Babak Tousi MD FACP
Dementia
Head, Clinical Trials Program, Cleveland Clinic Lou Ruvo Center for Brain Health- Cleveland. Associate Professor of Neurology and Medicine
Join to View Full Profile
9500 Euclid Ave U-10Cleveland, OH 44195
Phone+1 216-636-9467
Fax+1 216-636-2645
Dr. Tousi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Babak Tousi is a neurogeriatrician in Cleveland, OH and is affiliated with Cleveland Clinic. He received his medical degree from Tehran University of Medical Sciences School of Medicine and has been in practice 23 years. He is experienced in movement disorders, dementia, alzheimer's disease, parkinson's disease, and lewy body dementia.
Education & Training
- Cleveland Clinic FoundationFellowship, Movement Disorders - Neurology, 2003 - 2005
- Cleveland Clinic FoundationFellowship, Geriatric Medicine (Internal Medicine), 2002 - 2003
- Atlantic Health System/Morristown Medical CenterResidency, Internal Medicine, 1999 - 2002
- Tehran University of Medical Sciences School of MedicineClass of 1995, M.D.
Certifications & Licensure
- OH State Medical License 2002 - 2025
- American Board of Internal Medicine Geriatric Medicine
Awards, Honors, & Recognition
- Jennifer B Langston Community Award Alzheimer's Association, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease Start of enrollment: 2012 Apr 19
- Effect of NeuroAD on the Cognitive Function of Alzheimer Patients Start of enrollment: 2013 Oct 01
- Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Efficacy and safety of passive immunotherapies targeting amyloid beta in Alzheimer's disease: A systematic review and meta-analysis.Reina Tonegawa-Kuji, Yuan Hou, Bo Hu, Noah Lorincz-Comi, Andrew A Pieper
Plos Medicine. 2025-03-01 - Building expert consensus regarding sharing of individual research results in Alzheimer's disease research: a Delphi study protocol.Lauren R Sankary, Valerie Rico, Megan Zelinsky, Helen S Webster, Alan J Lerner
BMJ Open. 2024-08-24 - 5 citationsRelationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients.Dawn C Matthews, Jefferson W Kinney, Aaron Ritter, Randolph D Andrews, Erin N Toledano Strom
Alzheimer's & Dementia. 2024-07-09
Books/Book Chapters
Press Mentions
- New Alzheimer’s Drug Approved in Great BritainAugust 22nd, 2024
- Cleveland Hospitals Study Whether New Drug Can Prevent Alzheimer'sNovember 20th, 2023
- How We Learned to Be LonelyJanuary 6th, 2023
- Join now to see all
Professional Memberships
- Member
- Fellow
- Alzheimer's AssociationScientific Advisory Board Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: